Loading...
935106861
info@markelab.com
Precio
375€ (100 µg)
Gimsilumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CSF2/GM-CSF, Gimsilumab is a fully human monoclonal antibody that targets granulocyte-macrophage colony stimulating factor (GM-CSF).
Biosimilars
Human
Monoclonal
Human
CSF2/GM-CSF
Human
IgG1 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 1648796-29-5
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más